Shareholders’ equity

3 Months Ended

Oct. 31, 2024

Equity [Abstract]

Shareholders’ equity

Stockholders’ equity

The following table presents a summary of the Company’s share activity:

	Three months ended
	October 31,
	2024	2023
Ordinary shares:
Balance at beginning of period	232,171,182	232,171,182
Treasury shares canceled	(30,827,929)	—
Ordinary shares canceled	(201,343,253)	—
Balance at end of period	—	232,171,182
Common stock:
Balance at beginning of period	—	—
Common stock issued	201,343,253	—
Balance at end of period	201,343,253	—
Treasury shares:
Balance at beginning of period	(30,827,929)	(27,893,680)
Treasury shares canceled	30,827,929	—
Share repurchases	(1,310,163)	(697,398)
Treasury shares used to settle share-based compensation awards	248,690	208,115
Balance at end of period	(1,061,473)	(28,382,963)
Employee Benefit Trusts:
Balance at beginning of period	—	(274,031)
Employee Benefit Trust shares used to settle share-based compensation awards	—	253,212
Balance at end of period	—	(20,819)
Total shares outstanding at end of period	200,281,780	203,767,400

Employee Benefit Trusts

Two Employee Benefit Trusts had been previously established in connection with the Company’s discretionary share award plans and long-term incentive plans. During fiscal 2024, each of these trusts were terminated with all shares disbursed or sold.

Share Repurchases

Share repurchases are being made under an authorization that allows up to $4.0 billion in share repurchases. As of October 31, 2024, the Company had completed $3.4 billion of the total authorized $4.0 billion share repurchase program.

Ordinary Shares and Treasury shares

As of August 1, 2024, the Company canceled all ordinary shares in connection with its completion of the Merger. As a result, in the first quarter of fiscal 2025, 30,827,929 ordinary shares held in treasury were canceled, 201,343,253 of outstanding ordinary shares not held in treasury were canceled and 201,343,253 shares of common stock were issued as consideration therefor.